NIH OTT RSS Feed - Infectious Diseases - http://www.ott.nih.gov/rss/default.aspxOffice of Technology Transfer (OTT).Copyright 2009 NIH Office of Technology Transfer (OTT). All rights reserved.Live Attenuated RSV Vaccines Based on Codon-Pair Deoptimizationhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25702013-06-06Novel Fusion Proteins for HIV Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25672013-05-30A Novel Human Antibody for Deploying CH2 Based Therapeuticshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25682013-05-30A Novel HIV-1 Entry Inhibitorhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25662013-05-22A Diagnostic Kit for Assessing Exposure or Infection by the Koala Family of Retroviruseshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25612013-05-10Parvovirus B19 Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25602013-05-07Antimalarial Inhibitors that Target the Plasmodial Surface Anion Channel (PSAC) Protein and Development of the PSAC Protein as Vaccine Targetshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24882013-04-23New Molecules for HIV Therapeutics: Fab, scFv, and Related Binding Molecules Specific for HIV-1 Revhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22422013-04-17Improved Standard for Immune System Recovery Assayhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22512013-04-17HIV-Neutralizing Polypeptides: A Novel Use for Platelet Factor 4 or Its Derivativeshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25472013-04-04Infectious Hepatitis E Virus Genotype 3 Recombinants ? Prospective Vaccine Candidates and Vector Systemhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23292013-03-21Human Antibodies and Fusion Proteins with Potent and Broad HIV-1 Neutralizing Activityhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24822013-03-18Cross-Reactive Dengue Fully Human Monoclonal Antibodieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25082013-03-18Novel Diagnostic Marker for Prediction of Clearance of Hepatitis C Virus Infectionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25382013-03-18Novel Host Target for Treatment of Hepatitis C Virus Infectionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25392013-03-18Oral Shigellosis Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25282013-02-26Modified Peptide Nucleic Acids (PNAs) for Detection of DNA or RNA and Identification of a Disease or Pathogenhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25352013-02-21Novel Vaccine for Prevention and Treatment of Chlamydia Infectionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25362013-02-21Small, Stable, Functional, Soluble, Monomeric IgG1 Fc Molecules Engineered Therapieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25122013-02-19Live Oral Shigella dysenteriae Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25272013-02-16Mice Genetically Deficient in the Chemoattractant Receptor FPR (formyl peptide receptor)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=15742013-02-15Improved Bacterial Host for Production of Anthrax Toxin Proteins and Vaccines: Bacillus anthracis BH450http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=15992013-02-15Hepatitis C Virus Cell Culture Systemhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=16462013-02-15Murine Monoclonal Antibodies Effective To Treat Respiratory Syncytial Virushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=3522013-02-14Full-Length cDNA Clone Representing the Consensus Sequence of the RNA Genome of a Human Norovirus (strain MD145-12) That Encodes Biologically Active Proteinshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9032013-02-14Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9082013-02-14Construction of an Infectious Full-Length cDNA Clone of the Porcine Enteric Calicivirus RNA Genomehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9092013-02-14Construction of Recombinant Baculoviruses Carrying the Gene Encoding the Major Capsid Protein, VP1, From Calicivirus Strains (Including Norovirus Strains Toronto, Hawaii, Desert Shield, Snow Mountain, and MD145-12)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9102013-02-14HIV Therapeutics Utilizing Peptide Secreting Commensal Bacteriahttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=10002013-02-13Human Cells and Nanoparticles to Enhance Immunotherapyhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23012013-02-13Therapeutic Hepatitis C Virus Antibodieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25242013-02-05Live Attenuated Rubella Vector to Express Vaccine Antigenshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25252013-02-05DNA Promoters and Anthrax Vaccineshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25262013-02-05Multivalent Meningiococcal Conjugates and Methods for Preparing Conjugateshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25162013-01-23Transmission-Blocking Malaria Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25062013-01-11Methods and Composition for Identification of Variants of JC Virus DNA; An Etiologic Agent for Progressive Multifocal Leukoencephalopathy (PML)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25072013-01-11Typhoid-Plague Bivalent Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25092013-01-11Exposing T cells to Fas Ligand (FasL)-Fas Receptor (FasR) Antagonists Withholds Differentiation and Increases Expansion Making T cells More Suitable for Use in Cancer Immunotherapyhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24562012-12-04Gag-Based DNA Vaccines Against HIV99 of all known Gag sequences elicited strong, cellular T-cell and humoral antibody immune responses. The Gag-specific antibody responses were high titer and cross-clade. Cross-clade protection is important given the sequence diversity of HIV as is the absence of immunodominant epitopes that generate antibodies which are not protective against HIV.]]>http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25032012-11-21Topical Antibiotic with Immune Stimulating Oligodeoxynucleotide Molecules to Speed Wound Healinghttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24872012-11-19Cross-Reactive Neutralizing Human Domain Antibody Against HIV-1http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18092012-09-28Method of Making a Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18992012-09-28Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17362012-09-12Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruseshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=20052012-08-31Methods of Treating Giardiasis Using FDA-Approved Compoundshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23072012-08-17Filovirus Vaccines and Diagnostics Based on Glycoprotein-Fc Fusion Proteinshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23152012-08-17The Medusa? Sequencer: A DNA or RNA Sequencing Machine the Size of a Moleculehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=13222012-08-01Novel Infrared (IR)-Transparent Hydrophilic Membrane That Can be Used for Filtration, Printing or Microarrays, and Cultivation of Bacteria and Other Microorganisms for Reagent-Free IR Spectroscopic Identificationhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=13982012-07-31High Diversity/High Affinity Domain Antibody Libraryhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=19862012-07-31Purified Saxitoxin for Food Safety Applicationshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=20142012-07-31